In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
1853 News Items found
Jeffrey Drebin, Chair of the Department of Surgery at MSK
Q&A
Creating a Safe Space for Cancer Surgery at MSK: 5 Things to Know

MSK's Chair of the Department of Surgery discusses what people need to know about rescheduling treatment and what we're doing to keep you safe.
Craig B. Thompson, MD, President and Chief Executive Officer of Memorial Sloan Kettering Cancer Center
MSK’s Craig B. Thompson, MD, Joins New York Jobs CEO Council

MSK President and CEO, Craig B. Thompson, MD, has been named a founding member of the New York Jobs CEO Council. Dr. Thompson joins CEOs from 27 of the largest employers in New York in the new CEO-led, action-oriented coalition.
Crain’s Notable in Health Care in NYC List
MSK Leaders Recognized in Crain’s New York Business 2020 Notable in Healthcare List

The third-annual Crain’s New York Business Notable in Healthcare list celebrates outstanding individuals in the healthcare community within the New York metropolitan area, and honors their professional, civic, and philanthropic achievements.
Large International Study Pinpoints Impact of TP53 Gene Mutations on Blood Cancer Severity

Having two mutated copies of the TP53 gene — as opposed to a single mutated copy — is associated with worse outcomes in a blood cancer called myelodysplastic syndrome, according to a new study led by researchers at Memorial Sloan Kettering.
Joan Massagué, PhD
Spotlight Speaker: SKI Director, Joan Massagué, PhD

SKI Director, Joan Massagué, PhD, is an internationally renowned cancer biologist and leading researcher in the study of cancer metastasis. He is featured in the July 29 MSK Science Spotlight.
Alexander Rudensky, PhD
Shining a Spotlight on Pioneering Immunologist, Alexander Rudensky, PhD

The July 27 MSK Science Spotlight features Immunology Program Chair and Director of the Ludwig Center for Cancer Immunotherapy at MSK, Alexander Rudensky, PhD.
Dr. Lisa DeAngelis
Cancer Is Not Going Away During COVID-19: Physician-in-Chief Lisa DeAngelis Shares Why Patients Need to Get Back to the Clinic

Cancer institutions need to be vigilant in their approach to getting patients safely back to the clinic so they don’t further delay life-saving care.
Section of a lung cancer tumor in mice
Finding
A Never-Before-Seen Cell State May Explain Cancer’s Ability to Resist Drugs

Identified in mice, this unusual cell state emerges early during tumor evolution and gives tumors enormous malleability.
MSK Kids staff work on making the “We’re All in This Together” prom video
MSK Kids and Staff Dance Through 2020 with a “Mask-erade” Prom

MSK Kids staff made some clever tweaks and a few adjustments to host the ultimate “mask-erade” prom.
Luis Diaz, MD
Spotlight on Immunotherapy of Mismatch Repair Deficient Tumors

The July 22 MSK Science Spotlight features Luis Diaz, MD, Head of the Division of Solid Tumor Oncology and Grayer Family Chair, presenting his work on ”Immunotherapy of Mismatch Repair Deficient Tumors.”